fosinopril has been researched along with Recrudescence in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borghi, C; de Kam, PJ; Hochman, JS; van den Berg, MP; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
De Scheerder, I; Desmet, W; Piessens, J; Van Lierde, J; Vrolix, M; Willems, JL | 1 |
Nadeeva, OI; Smirnov, AA; Uvarov, AV; Uzhegov, KS | 1 |
3 trial(s) available for fosinopril and Recrudescence
Article | Year |
---|---|
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fibrinolytic Agents; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Recurrence; Risk Factors; Survival Analysis; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2005 |
Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Fosinopril; Humans; Male; Middle Aged; Recurrence; Time Factors | 1994 |
[The application of fozinopril in the treatment of refractory angina pectoris in elderly patients].
Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Fosinopril; Humans; Recurrence; Severity of Illness Index | 1999 |